A study has revealed that an immune system protein may help detect lung cancer in the early stages.
In the study, the researchers analysed blood samples from 50 healthy volunteers and 104 people with various types of lung cancer.
Early Detection of Lung Cancer: New Blood Protein Biomarker
A blood protein that is present in all stages of lung cancer has been identified by a team of researchers.
Advertisement
They tested for autoantibodies, an immune system protein directed at the body's own tissues in response to specific chemical signals in the body.
They looked specifically for a panel of seven autoantibodies, which are associated with 'solid tumours,' such as lung, breast, ovarian, and prostate cancers, and triggered when cancerous changes take place.
The analysis showed the presence of all the seven autoantibodies, and very high levels of at least one of the seven in almost eight out of 10 samples taken from patients with confirmed lung cancer.
The autoantibodies were found in eight out of the nine patients whose cancer had not infiltrated the lymph nodes, body's gatekeepers.
The results indicated that the disease had not yet extended elsewhere and offered 80 percent chances of cure and only one healthy volunteer had more than one of the autoantibodies in their blood. .
The study is published in the journal Thorax.
Source: ANI
GAN /J
Advertisement
The analysis showed the presence of all the seven autoantibodies, and very high levels of at least one of the seven in almost eight out of 10 samples taken from patients with confirmed lung cancer.
The autoantibodies were found in eight out of the nine patients whose cancer had not infiltrated the lymph nodes, body's gatekeepers.
The results indicated that the disease had not yet extended elsewhere and offered 80 percent chances of cure and only one healthy volunteer had more than one of the autoantibodies in their blood. .
The study is published in the journal Thorax.
Source: ANI
GAN /J
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News
The combination of the personalized cancer vaccine with ACT led to ovarian cancer control in few patients within a span of three months, stated study results.
Uncovering key kinases in tumor growth and invasion is crucial for improving targeted therapies in advanced-stage colorectal cancer.
The study findings validate metal-enhanced photo-oxidation for future metal-based anticancer drugs.
Mutations in 11 genes are linked to aggressive forms of prostate cancer, which may present novel therapeutic and therapy options.
Improved oral health, as indicated by the count of natural teeth and dental appointments preceding the diagnosis, correlated with enhanced head and neck cancer survival rates.
